Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Types of HIV tests news

Show

From To
Rwanda to allow pharmacies sell oral HIV self-testing kits

Selected pharmacies in the Rwandan capital Kigali are in line to begin selling over-the- counter oral HIV self-testing kits, Rwanda’s New Times Daily has reported. The report added that the price of the kit had also been slashed by half as a result of a government-private sector partnership. It said over 20 pharmacies in Kigali were receiving training on how to administer the kits.

Published
01 June 2018
From
Africanews
Early HIV diagnosis in infants works in Africa, but the technology must spread to save lives

For infants born with HIV, a rapid introduction to necessary treatment is often the lifeline between whether a child will live or die. The recent introduction of a life-saving, point-of-care diagnostic technology in sub-Saharan Africa could become a global solution to preventing infant deaths from HIV.

Published
23 February 2018
From
Devex
Multi-disease testing offers new ways to streamline disease management, Unitaid report says

Innovators are responding to the world’s growing co-infection crisis by developing devices that can quickly, accurately diagnose multiple diseases at a time. Unitaid’s new landscape report, launched today, profiles more than 95 such devices, already on the market or in development, all of which address at least one of Unitaid’s key disease areas—HIV, hepatitis C (HCV), tuberculosis (TB) and malaria.

Published
02 February 2018
From
Unitaid
A More Sensitive Saliva-Based HIV Test Is in the Works

Preliminary experiments suggest that the investigatory saliva test can identify HIV earlier in the course of infection compared with currently available spit-based assays. However, this experimental test will not likely identify new HIV infections as early as a blood test can.

Published
25 January 2018
From
Poz
Alere Detect Effective as Rapid HIV-2 Test

The Alere q HIV-1/2 Detect test (Alere) can differentiate between HIV-1 and HIV-2 in 100% of samples, according to a new study. The test is the only point-of-care nucleic acid test (NAT) currently able to detect HIV-2.

Published
07 December 2017
From
Infectious Disease Special Edition
CE Marking for world’s only integrated HIV Self-Test from Atomo Diagnostics

Atomo HIV Self Test granted CE Mark; will facilitate rollout in European and other global markets. Test will be available commercially during 2018 via retail, e-commerce and public health channels.

Published
13 October 2017
From
Atomo press release
MHRA seizes more than 100 unreliable HIV home-testing kits

MHRA are investigating a number of Hightop HIV/AIDS Home Test Kits that may be unreliable and may provide false results.

Published
22 August 2017
From
Medicines and Healthcare products Regulatory Agency
OraSure Technologies Receives World Health Organization Prequalification of OraQuick® HIV Self-Test

OraSure Technologies, Inc., a leader in point of care diagnostic tests and specimen collection devices, today announced that its OraQuick® HIV Self-Test (HIVST) has been Prequalified by the World Health Organization (WHO).

Published
22 July 2017
From
Orasure press release
South Africa: First HIV test approved for home use to hit shelves

BioSURE HIV Self Test is described by its makers as “South Africa’s only CE-marked HIV self-test and the first HIV test approved for use at home without a medical professional”.

Published
12 May 2017
From
The Citizen
Kenya launches self-test kits and PrEP

The Government of Kenya has reinforced its commitment to end AIDS by 2030 by launching two innovative technologies: self-testing for HIV and PrEP.

Published
05 May 2017
From
UNAIDS
← First12345...14Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.